Cellectis
CLLS
70 hedge funds and large institutions have $210M invested in Cellectis in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 6 closing their positions.
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
11% more funds holding
Funds holding: 63 → 70 (+7)
1.4% more ownership
Funds ownership: 30.26% → 31.65% (+1.4%)
10% more call options, than puts
Call options by funds: $905K | Put options by funds: $823K
0% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 23
10% less capital invested
Capital invested by funds: $234M → $210M (-$24.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
+$7.51M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
+$7.18M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$7.01M |
| 4 |
Morgan Stanley
New York
|
+$3.19M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$8.22M |
| 2 |
BlackRock
New York
|
-$5.64M |
| 3 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
-$4.47M |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.12M |
| 5 |
JP Morgan Chase
New York
|
-$1.11M |
CLLS Hedge Fund Activity: Q2 2019 in Review
70 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q2 2019, worth a combined $210M — down 10% from $234M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new CLLS positions and 6 closed out — a net gain of 7 holders — while 23 added to existing stakes and 23 trimmed.
The largest buyer was Capital International Investors, opening a new position worth an estimated $7.51M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $8.22M sold.
- 70 institutional investors held Cellectis (CLLS) as of Q2 2019, up from 63 in Q1 2019.
- Funds reported $210M of Cellectis stock for Q2 2019, down 10% quarter-over-quarter.
- 13 funds opened new Cellectis positions in Q2 2019 and 6 closed out, a net change of +7 holders.
- The largest Cellectis buyer in Q2 2019 was Capital International Investors, an estimated $7.51M added.
- The largest Cellectis seller in Q2 2019 was Sphera Funds Management, an estimated $8.22M sold.
Based on aggregated 13F filings for Q2 2019.